Exelixis Inc
(NAS:EXEL)
$
56.51
-0.60 (-1.05%)
Market Cap: 14.20 Bil
Enterprise Value: 13.59 Bil
PE Ratio: 18.77
PB Ratio: 7.40
GF Score: 92/100 Exelixis Inc at Jefferies Healthcare Conference Transcript
Jun 08, 2022 / 05:30PM GMT
Release Date Price:
$19.22
(-1.28%)
Akash Tewari
Jefferies LLC, Research Division - Equity Analyst
So good afternoon, everyone. I hope you're all doing well. I have the -- for those who don't know me, my name is Akash Tewari. I'm a biotech analyst here at Jefferies. I have the pleasure of hosting Mike Morrissey, President and CEO of Exelixis. Mike has been kind enough to join us even after going through ASCO, which I can't imagine would have pain that must have...
Michael M. Morrissey
Exelixis, Inc. - CEO, President & Director
It's been a long week. Yes.
Akash Tewari
Jefferies LLC, Research Division - Equity Analyst
It's been a long week for him, but he is nice enough to still join us. Mike, why don't I give it to you for just some brief introductory remarks, and then we can get into the space together.
Michael M. Morrissey;Akash Tewari
Exelixis, Inc. - CEO, President & Director;Jefferies LLC, Research Division
Thanks again for the invite. Good to see you again.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot